Genomictree Inc. (KOSDAQ:228760)
13,870
-990 (-6.66%)
Aug 12, 2026, 3:30 PM KST
Genomictree Market Cap
Genomictree has a market cap or net worth of 364.46 billion as of August 11, 2026. Its market cap has increased by 0.09% in one year.
Market Cap
364.46B
Enterprise Value
289.44B
Revenue
3.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,870.00
ChartMarket Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 364.46B, an increase of 517.75%. That is a compound annual growth rate of 21.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 364.46B | -44.73% |
| Dec 30, 2025 | 659.41B | 34.41% |
| Dec 30, 2024 | 490.60B | 0.78% |
| Dec 28, 2023 | 486.82B | 168.25% |
| Dec 29, 2022 | 181.48B | -32.87% |
| Dec 30, 2021 | 270.36B | -7.66% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GI Innovation | 551.61B |
| Medy-Tox | 520.10B |
| GC Corp. | 468.09B |
| MEDIPOST | 384.99B |
| SillaJen | 311.75B |
| Proteina | 285.81B |
| BINEX | 221.02B |
| GC Cell | 219.85B |